CASP9 and breast cancer: It was confirmed by the analysis in Annexin V binding assay, as well as our observation of the increased caspase-8 and caspase-9 concentrations and decreased mitochondrial membrane potential in comparison with the untreated control in both MCF-7 and MDA-MB-231 breast cancer cells.